Company / Cost of Revenue
HeartSciences Inc. Cost of Revenue History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$6.1K
FY2025
5-year range
$2.8K / $7.9K
FY2023-FY2025
Trend
+117.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $7,890 to $6,081 over the past 2 years.
Based on SEC 10-K filings.
$6,081 in FY2025.
Improved from $7,890 to $6,081 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cost of revenue increased 117.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -5.89 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.1K | +117.5% |
| FY2024 | $2.8K | -64.6% |
| FY2023 | $7.9K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026